10x Genomics, Inc. Annual Net Cash Provided by (Used in) Financing Activities in USD from 2017 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
10x Genomics, Inc. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from 2017 to 2023.
  • 10x Genomics, Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2024 was $1.64M.
  • 10x Genomics, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was $13.7M, a 13.6% decline from 2022.
  • 10x Genomics, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was $15.8M, a 55.2% decline from 2021.
  • 10x Genomics, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2021 was $35.3M, a 92.5% decline from 2020.
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $13.7M -$2.15M -13.6% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-15
2022 $15.8M -$19.5M -55.2% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-15
2021 $35.3M -$434M -92.5% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-15
2020 $469M +$54.3M +13.1% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-16
2019 $415M +$309M +293% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-18
2018 $105M +$84.8M +412% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-26
2017 $20.6M Jan 1, 2017 Dec 31, 2017 10-K 2020-02-27
* An asterisk sign (*) next to the value indicates that the value is likely invalid.